Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin for prevention of anthracycline-related cardiac injury
MOH_2021-06-10_010037Phase 3Not yet recruiting
- Sponsor
- דר' יאוב גרנות
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Anthracycline Cardiomyopathy comparing Jardiance with Placebo (2 arms). Planned start Mar 2021; status: not yet recruiting.
02
Drugs
empagliflozin
03
Conditions
Anthracycline Cardiomyopathy
Beyond the preview
Go deeper on MOH_2021-06-10_010037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-06-10_010037.